Pfizer (PFE) Buy Rating Maintained at Deutsche Bank, Price Target Raised to $35
Tweet Send to a Friend
Deutsche Bank maintained a Buy rating on Pfizer (NYSE: PFE) and raised its price target to $35.00 (from $34.00). Analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
